IRIS UniCatt

Marino, Mariapaola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.243
AS - Asia 2.258
EU - Europa 2.015
SA - Sud America 543
AF - Africa 58
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.134
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.126
SG - Singapore 1.134
CN - Cina 569
SE - Svezia 546
BR - Brasile 462
IT - Italia 325
DE - Germania 320
FR - Francia 170
IE - Irlanda 128
GB - Regno Unito 116
VN - Vietnam 103
IN - India 101
ID - Indonesia 82
UA - Ucraina 75
RU - Federazione Russa 67
FI - Finlandia 64
CA - Canada 60
PL - Polonia 54
MX - Messico 43
JP - Giappone 39
BD - Bangladesh 37
HK - Hong Kong 33
AR - Argentina 31
TR - Turchia 28
BE - Belgio 27
KR - Corea 27
ZA - Sudafrica 25
ES - Italia 23
NL - Olanda 23
IQ - Iraq 19
AT - Austria 18
EC - Ecuador 13
CH - Svizzera 11
CI - Costa d'Avorio 11
CO - Colombia 11
UZ - Uzbekistan 11
IR - Iran 10
AU - Australia 9
CZ - Repubblica Ceca 9
MA - Marocco 9
PK - Pakistan 9
SA - Arabia Saudita 9
JO - Giordania 7
BY - Bielorussia 6
LT - Lituania 6
NZ - Nuova Zelanda 6
VE - Venezuela 6
CL - Cile 5
KE - Kenya 5
KZ - Kazakistan 5
LB - Libano 5
PY - Paraguay 5
AL - Albania 4
IL - Israele 4
NO - Norvegia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HU - Ungheria 3
KG - Kirghizistan 3
LK - Sri Lanka 3
PH - Filippine 3
PT - Portogallo 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
GA - Gabon 2
HN - Honduras 2
JM - Giamaica 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
TM - Turkmenistan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BG - Bulgaria 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
GY - Guiana 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MY - Malesia 1
OM - Oman 1
SC - Seychelles 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 8.134
Salva come PNG Salva come JPEG
Città #
Singapore 570
Chandler 532
Ashburn 435
New York 141
Beijing 135
Dublin 128
Los Angeles 116
San Mateo 89
Rome 88
Dallas 77
Hefei 77
Jakarta 76
North Bergen 57
Boston 56
Milan 53
Marseille 52
The Dalles 50
Cattolica 49
Munich 49
Wilmington 49
São Paulo 47
Chicago 46
Princeton 46
Ann Arbor 45
Moscow 43
Frankfurt am Main 42
Jacksonville 42
Ho Chi Minh City 38
Houston 37
Tokyo 37
Bremen 35
Redwood City 33
Helsinki 31
Hong Kong 30
Boardman 29
Dearborn 26
Santa Clara 26
Woodbridge 26
Hanoi 25
Nanjing 25
Hyderabad 23
Seoul 23
Warsaw 23
Kent 22
Brussels 21
Atlanta 20
Montreal 19
Nuremberg 19
Orem 19
Seattle 19
Denver 18
Bologna 17
Buffalo 17
Kraków 17
Brooklyn 16
Chennai 16
Johannesburg 16
London 16
Falls Church 15
Norwalk 15
Rio de Janeiro 15
San Francisco 15
Stockholm 15
Toronto 15
Lappeenranta 12
Abidjan 11
Amsterdam 11
Des Moines 11
Falkenstein 11
Manchester 11
Phoenix 11
Turku 11
Brasília 10
Dhaka 10
Fairfield 10
Mexico City 10
Poplar 10
Querétaro 10
Tashkent 10
Washington 10
Baghdad 9
Belo Horizonte 9
Düsseldorf 9
Edinburgh 9
Lawrence 9
Nanchang 9
Roubaix 9
Wroclaw 9
Ankara 8
Bexley 8
Charlotte 8
Curitiba 8
Hebei 8
San Jose 8
Vienna 8
Amman 7
Chengdu 7
City of London 7
Fortaleza 7
Izmir 7
Totale 4.351
Salva come PNG Salva come JPEG
Nome #
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 238
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 201
T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients 185
A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation 181
PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data 168
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 166
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 159
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 151
Human Leukocyte Antigen Class II associations in late-onset Myasthenia Gravis 148
IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. 146
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 145
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 145
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 142
Myasthenia gravis with antibodies to MuSK: an update 137
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 137
Immunological role of IgG subclasses 137
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 135
Skeletal muscle cells: from local inflammatory response to active immunity 130
HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. 130
Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. 124
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? 124
Fluidi ed elettroliti. Equilibrio acido-base 119
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 118
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 118
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 116
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 116
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 115
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 115
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 115
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 113
Immunological role of IgG subclasses 113
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function 112
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 109
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 104
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 104
Epidemiological evidence for a hereditary contribution to myasthenia gravis: A retrospective cohort study of patients from North America 102
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 99
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 99
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 98
The Laboratory Role in anti-TNF Biological Therapy Era 96
Evaluation of free light chains of immunoglobulins in normal and pathological seminal fluids: Preliminary data 95
Anti-Inflammatory Effects of Curcumin-Based Nanoparticles Containing α-Linolenic Acid in a Model of Psoriasis In Vitro 91
A comparative study of serum angiogenic biomarkers in cirrhosis and hepatocellular carcinoma 91
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 90
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 90
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 89
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis 88
Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy 87
Anti-MuSK antibodies: Correlation with myasthenia gravis severity 87
Cryoglobulins: putative effectors of adaptive immune response 87
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients 86
IL-6, monocyte infiltration and parenchymal cells 85
Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AI 84
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus 83
Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement 83
Identification of disease-specific autoantibodies in seronegative myasthenia gravis 81
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 80
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes 80
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis 79
Free light chains and autoimmunity 76
The dark side of current analytic methods for Bence Jones Proteinuria 75
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients 74
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 74
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus 73
Type 2 cytokines and scleroderma interstitial lung disease 71
Tumor necrosis factor-alpha: ally and enemy in protean cutaneous sceneries 70
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 66
Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker? 64
A new challenge for urinary free light chains: assessment of the upper reference limit in healthy subjects 61
Distinct Biomarker Profiles of B-Cell Activation in Metabolic and Viral Hepatic Fibrosis 59
Calprotectin: two sides of the same coin 58
Immune-inflammatory response changes in patients with major depressive disorder 58
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 55
The Evolution of Serological Assays during Two Years of the COVID-19 Pandemic: From an Easy-to-Use Screening Tool for Identifying Current Infections to Laboratory Algorithms for Discovering Immune Protection and Optimizing Vaccine Administration 55
In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement 54
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand? 54
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 54
Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts 52
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 39
Cryoproteins in Non-HCV-Related Autoimmune Disorders: A Serious Cold-Induced Problem 39
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 38
Assessment of Cardiorenal Involvement in Systemic Sclerosis Patients 27
Totale 8.292
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.317
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021135 0 0 0 0 0 16 16 8 22 6 53 14
2021/2022600 24 15 13 63 56 21 12 98 32 26 103 137
2022/20231.491 223 198 94 236 69 163 84 140 155 28 70 31
2023/2024852 35 180 19 89 33 131 54 35 13 51 91 121
2024/20251.866 75 68 131 66 143 85 51 110 308 157 386 286
2025/20262.651 579 121 324 682 901 44 0 0 0 0 0 0
Totale 8.292